High-activity glutathion peroxidase GPX 1 mutant and its preparation method
A technology of glutathione peroxide and mutant, applied in the biological field, can solve the problems of loss of enzyme protein, toxicity, and unsuitability for direct expression of selenoproteins.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0100] Example 1: Preparation of genetically engineered human GPX1 mutant protein using a synthetic gene combined with SPP and auxotrophic prokaryotic expression system
[0101] According to the amino acid sequence of the GPX1 mutant described in Sequence 1 (SEQ ID No: 1) of the present invention, artificially synthesized by a DNA synthesizer in a biological company, it can express the description in Sequence 1 (SEQ ID No: 1) in an auxotrophic strain For the gene of the GPX1 mutant protein, ensure that the 5' end of the GPX1 mutant gene contains a start codon (ATG) and an Nde I restriction site, and the 3' end contains a stop codon and a Hind III restriction site, and the GPX1 mutation The coding sequence TGA of No. 49 SeCys of the body gene was replaced with the codon of Cys (TGC), and the full length of the gene did not contain the ACA sequence; the specific target gene sequence was the GPX1 gene (see NCBI, NM_000581.2). The codons of cysteine at positions 78, 115, 156 and...
Embodiment 2
[0104] Example 2: Preparation of genetically engineered human GPX1 mutant protein by gene amplification and mutation method and SPP combined with auxotrophic prokaryotic expression system
[0105] mRNA was extracted from human HepG-2 (DSMZ#ACC180) liver cancer cells using the mRNA mini-extraction kit (Sigma, Cat#MRN-10), and reverse transcriptase (AMV RT, Promega, Cat#M5101) and oligo(dT ) was transcribed into cDNA by RT-PCR (Reverse Transcription Polymerase Chain Reaction). According to the human GPX1 gene sequence published in the gene library (see NCBI, NM_000581.2), primers were designed to amplify its coding gene, ensuring that the 5′ end of the gene contained an initiation codon (ATG) and an Nde I restriction site, 3 The 'end contains a stop codon and a Hind III restriction site, and the codons of the 2nd and 202nd Cys are replaced by the codons of Ser, and the other amino acid sequences remain unchanged; the specific 5' end primer is 5'-GGAATTCCATATGAGTGCTGCTCGGC- 3', ...
Embodiment 3
[0108] Example 3: Preparation of genetically engineered human GPX1 mutant protein with synthetic genes and auxotrophic prokaryotic expression system
[0109] According to the amino acid sequence of the GPX1 mutant described in Sequence 1 (SEQ ID No: 1) of the present invention, artificially synthesized by a DNA synthesizer in a biological company, it can express the description in Sequence 1 (SEQ ID No: 1) in an auxotrophic strain For the gene of the GPX1 mutant protein, ensure that the 5' end of the GPX1 mutant gene contains a start codon (ATG) and an Nde I restriction site, and the 3' end contains a stop codon and a Hind III restriction site, and the GPX1 mutation The coding sequence TGA of No. 49 SeCys of the body gene was replaced with the codon of Cys (TGC); the specific target gene sequence was the 2nd, 78th, 115th, 156th and 202nd in the GPX1 gene (see NCBI, NM_000581.2) The codon of cysteine is replaced by the coding sequence of serine (in sequence: AGT, AGC, AGC, AG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com